New colposcopy terminology was prepared by the Nomenclature Committee of the
International Federation of Cervical Pathology and Colposcopy after a critical review of …

BACKGROUND Human epididymis protein 4 (HE4), a precursor of human epididymis
protein, has been proposed as a tumor marker for ovarian cancer. We evaluated HE4 in …

Objective Using highly sensitive polymerase chain reaction (PCR) techniques, we
reanalysed all cervical carcinomas (CC s) found to be human papillomavirus (HPV) …

Introduction: Although human papillomavirus (HPV) routine vaccination programmes have
been implemented around the world and recommendations have been expanded to include …

The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125
and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients …

OBJECTIVE.: To evaluate whether high-risk human papillomavirus (HR-HPV) detection and
viral load prior to treatment and status of cone margins can predict residual/recurrent …

Cervical glandular neoplasias (CGN) present a challenge for cervical cancer prevention due
to their complex histopathology and difficulties in detecting preinvasive stages with current …

We tested 417 cases of formalin-fixed, paraffin-embedded normal or hyperplastic
gynecologic tissues as well as neoplasms involving the gynecologic tract with a monoclonal …

The aim of this study was to evaluate the feasibility, efficacy, and morbidity of laparoscopic
ovarian transposition on the preservation of hormonal function in patients younger than 45 …

Abstract Background SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multicentre,
prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic …